Protagenic Therapeutics achieves milestone in Phase I trial for PT00114, a compound for treating stress-related neuro-psychiatric disorders. No adverse reactions ...
ZNet Technologies and Virtuozzo have partnered to enhance the technological infrastructure in India and South-East Asia. This collaboration will bring ...